Company: VRCA
Filing Date: 2025-12-15
Form Type: S-3
Source: 0001193125-25-319225
Chunk: 0

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-12-15
Form: S-3
Chunk 0
---
As filed with the Securities and Exchange Commission on December 15, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VERRICA PHARMACEUTICALS INC. (Exact name of registrant as specified in its charter)

| Delaware                                                       |     | 46-3137900                             |
| (State or other jurisdiction of incorporation or organization) |     | -I.R.S. Employer Identification Number |

44 West Gay Street, Suite 400 West Chester, PA 19380 (484) 453-3300 (Address, including zip code, and telephone number, including area code of registrant’s principal executive offices) Jayson Rieger President and Chief Executive Officer 44 West Gay Street, Suite 400 West Chester, PA 19380 (484) 453-3300 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Mark Ballantyne Divakar Gupta Cooley LLP 11951 Freedom Drive Reston, VA 20190-5640 (703) 456-8000 From time to time after the effective date of this Registration Statement (Approximate date of commencement of proposed sale to the public) If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐ If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐ If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.